AMGN

Recent Articles

Is the SPDR S&P Biotech (ETF) (XBI) Done Running?

Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading. More 

5 Biotech Stocks That Are Roaring Back to Life

These biotech stocks are making their way past recent lows based on a potential pause in focus and action by Trump. More 

3 Biotech Trades to Diversify Your Portfolio

There’s always a bull market somewhere. At times, there are bulls and bears in the same sector, as is the case with these biotech stocks. More 

Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy?

Teva's recent migraine drug data, while positive, didn't impress investors. What happened, and should you tussle with TEVA stock? More 

Stocks Climb During Trump’s First International Visit

In the end, the Dow Jones gained 0.4%, the S&P 500 gained 0.5%, the Nasdaq gained 0.8% and the Russell 2000 added 0.7%. More 

Why Amgen, Inc. (AMGN), Advanced Micro Devices, Inc. (AMD) and Forterra Inc (FRTA) Are 3 of Today’s Worst Stocks

Forterra (FRTA), Advanced Micro Devices (AMD) and Amgen (AMGN) shareholders ended up wishing last weekend was a three-day break. More 

3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)

Bristol-Myers Squibb (BMY), Pfizer (PFE) and Amgen (AMGN) are teasing the technical traders as their charts suggest the potential for a short-term buying opportunity. More